Annex DTR3
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
All relevant boxes should be completed in block capital letters
1. |
Name of the Issuer:
Hikma Pharmaceuticals PLC |
2. |
State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.2 R, (ii) a disclosure made in accordance with LR 9.8.6R(1) or (iii) a disclosure made in accordance with section 793 of the Companies Act (2006): DTR 3.1.2 R |
3. |
Name of person discharging managerial responsibilities/director: Mohammed Ali Khaldoun S Al-Husry |
4. |
State whether notification relates to a person connected with a person discharging managerial responsibilities/ director named in 3 and identify the connected person: Nisreen Z. Sh. Oun Alsharifeh (wife) Tala M. A. KH. Al-Husry (daughter) Haya M.A. KH. Al-Husry (daughter) Faisal Sate M. A. KH. Al Husry (son) |
5. |
Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest: All persons in 3 and 4 and their shareholdings in Hikma (whether direct or indirect) |
6. |
Description of shares (including class), debentures or derivatives or financial instruments relating to shares: Ordinary Shares in Hikma Ordinary Shares in Darhold Limited, the holding vehicle for shares in Hikma |
7. |
Name of registered shareholders(s) and, if more than one, the number of shares held by each of them: DYKB Limited, a British Virgin Islands company which is acting as a holding company for the Al-Husry family. |
8. |
State the nature of the transaction: Encumbrance in support of a loan of the shareholdings in Hikma and Darhold belonging to DKYB Limited, on behalf of the persons noted in 3 and 4, above.
|
9. |
Number of shares, debentures or financial instruments relating to shares acquired: None |
10. |
Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage): N/A |
11. |
Number of shares, debentures or financial instruments relating to shares disposed: None |
12. |
Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage): N/A |
13. |
Price per share or value of transaction: N/A |
14. |
Date and place of transaction: London, 27 June 2014
|
15. |
Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage): 5,109,748 (2.61%) shares in Hikma comprising: Directly: 1,109,748 (0.59%) Indirectly through Darhold limited: 4,000,000 (2.02%) |
16. |
Date issuer informed of transaction: 27 June 2014 |
If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes |
|||
17. |
Date of grant |
18. |
Period during which or date on which exercisable |
19. |
Total amount paid (if any) for grant of the option |
20. |
Description of shares or debentures involved (class and number) |
21. |
Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise |
22. |
Total number of shares or debentures over which options held following notification |
23. |
Any additional information |
24. |
Name of contact and telephone number for queries |
Name of authorised official or issuer responsible for making notification |
Peter Speirs, Company Secretary, Hikma Pharmaceuticals PLC |
Date of notification: 27 June 2014 |
Notes:
This form is intended for use by an issuer to make a RIS notification required by DTR 3.1.4
(1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.
(2) An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.
(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.
(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.